Trial Profile
A Phase II, Open-label, Multicentre Study of PM060184 in Patients With Advanced Colorectal Cancer After Standard Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Plocabulin (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Sponsors PharmaMar
- 30 Apr 2021 Status changed from active, no longer recruiting to completed.
- 28 Feb 2019 This trial has been completed in Spain, according to European Clinical Trials Database.
- 12 Feb 2018 New trial record